Summary
Nicotine research has proliferated alarmingly in recent years and the profusion of data makes it hard to maintain a critical eye on developments outside one’s immediate speciality. In this brief review, I discuss a number of widely-held views which I believe deserve to be questioned.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Wada E, Wada K, Boulter J, Deneris E, Heinemann S, Patrick J, Swanson LW.: Distribution of alpha 2, alpha 3, alpha 4, and beta 2 neuronal nicotinic receptor subunit mRNAs in the central nervous system: a hybridization histochemical study in the rat. J Comp Neurol 1989; 284: 314–335.
Clarke PBS, Schwartz RD, Paul SM, Pert CB, Pert A.: Nicotinic binding in rat brain: autoradiographic comparison of 3H-acetylcholine, ‘H-nicotine, and 125I-alpha-bungarotoxin. J Neurosci 1985; 5: 1307–1315.
Schroder H, Zilles K, Maelicke A, Hajos F.: Immunohisto-and cytochemical localization of cortical nicotinic cholinoceptors in rat and man. Brain Res 1989; 502: 287–295.
Hill JA Jr, Zoli M, Bourgeois J-P, Changeux J-P.: Immunocytochemical localization of a neuronal nicotinic receptor: The ß2-subunit. J Neurosci 1993; 13: 1551–1568.
Wonnacott S, Irons J, Rapier C, Thorne B, Lunt GG.: Presynaptic modulation of transmitter release by nicotinic receptors. Prog Brain Res 1989; 79: 157–163.
Clarke PBS, Reuben M, El-Bizri H.: Blockade of nicotinic responses by physostigmine, tacrine and other cholinesterase inhibitors in rat striatum. Br J Pharmacol 1994; 111: 695–702.
Clarke PBS.: Nicotinic receptors in mammalian brain: localization and relation to cholinergic function. Prog Brain Res 1993; 98: 77–83.
El-Bizri H, Clarke PBS.: Blockade of nicotinic receptor-mediated release of dopamine from striatal synaptosomes by chlorisondamine and other nicotinic antagonists administered in vitro. Br J Pharmacol 1994; 111: 406–413.
Clarke PBS, Chaudieu I, El-Bizri H, Boksa P, Quik M, Esplin BA, Capek R.: The pharmacology of the nicotinic antagonist, chlorisondamine, investigated in rat brain and autonomic ganglion. Br J Pharmacol 1994; 111: 397–405.
Flores CM, Rogers SW, Pabreza LA, Wolfe BB, Kellar KJ.: A subtype of nicotinic cholinergic receptor in rat brain is composed of a4 and 82 subunits and is up-regulated by chronic nicotine treatment. Mol Pharmacol 1992; 41: 31–37.
Takayama H, Majewska MD, London ED.: Interactions of noncompetitive inhibitors with nicotinic receptors in the rat brain. J Pharmacol Exp Ther 1989; 251: 1083–1089.
London ED, Connolly RJ, Szikszay M, Wamsley JK, Dam M.: Effects of nicotine on local cerebral glucose utilization in the rat. J Neurosci 1988; 8: 3920–3928.
Benwell ME, Balfour DJ, Anderson JM.: Evidence that tobacco smoking increases the density of (-)[3Hlnicotine binding sites in human brain. J Neurochem 1988; 50: 1243–1247.
Stolerman IP, Fink R, Jarvik ME.: Acute and chronic tolerance to nicotine measured by activity in rats. Psychopharmacologia 1973; 30: 329–342.
Clarke PBS, Kumar R.: The effects of nicotine on locomotor activity in non-tolerant and tolerant rats. Br J Pharmacol 1983; 78: 329–337.
Marks MJ, Stitzel JA, Collins AC.: Time course study of the effects of chronic nicotine infusion on drug response and brain receptors. J Pharmacol Exp Ther 1985; 235: 619–628.
Mitchell SN, Smith KM, Joseph MH, Gray JA.: Increases in tyrosine hydroxylase messenger RNA in the locus coeruleus after a single dose of nicotine are followed by time-dependent increases in enzyme activity and noradrenaline release. Neuroscience 1993; 56: 989–997.
El-Bizri H, Clarke PBS.: Regulation of nicotinic receptors in rat brain following quasi-irreversible nicotinic blockade by chlorisondamine and chronic treatment with nicotine. Br J Pharmacol 1994: in press.
Stolerman IP, Goldfarb T, Fink R, Jarvik ME.: Influencing cigarette smoking with nicotine antagonists. Psychopharmacologia 1973; 28: 247–259.
Corrigall WA, Franklin KBJ, Coen KM, Clarke PBS.: The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine. Psychopharmacology (Berl) 1992; 107: 285–289.
Engberg G, Hajos M.: Nicotine-induced activation of locus coeruleus neurons-An analysis of peripheral versus central induction. Naunyn Schmiedebergs Arch Pharmacol 1994; 349: 443–446.
Tang JL, Law M, Wald N.: How effective is nicotine replacement therapy in helping people to stop smoking. BMJ 1994; 308: 21–26.
Clarke PBS.: Nicotinic receptor blockade therapy and smoking cessation. Br J Addict 1991; 86: 501–505.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Birkhäuser Verlag Basel
About this chapter
Cite this chapter
Clarke, P.B.S. (1995). Current Controversies in Nicotine Research. In: Clarke, P.B.S., Quik, M., Adlkofer, F., Thurau, K. (eds) Effects of Nicotine on Biological Systems II. Advances in Pharmacological Sciences. Birkhäuser Basel. https://doi.org/10.1007/978-3-0348-7445-8_1
Download citation
DOI: https://doi.org/10.1007/978-3-0348-7445-8_1
Publisher Name: Birkhäuser Basel
Print ISBN: 978-3-0348-7447-2
Online ISBN: 978-3-0348-7445-8
eBook Packages: Springer Book Archive